Strongbridge Biopharma plc

(NASDAQ:SBBP)

Latest On Strongbridge Biopharma plc (SBBP):

Date/Time Type Description Signal Details
2021-10-06 17:04 ESTNewsXeris Pharmaceuticals completes Strongbridge deal after Ireland High Court approvalN/A
2021-09-22 05:38 ESTNewsXeris' rises 5% as stockholders approve Strongbridge Biopharma acquisitionN/A
2021-09-09 11:29 ESTNewsStrongbridge Biopharma shareholders vote in favor of Xeris dealN/A
2021-08-05 12:47 ESTNewsStrongbridge Biopharma EPS misses by $0.08, beats on revenueN/A
2021-07-21 23:53 ESTNewsStrongbridge Biopharma soars 17% after being acquired by Xeris PharmaN/A
2021-07-21 23:52 ESTNewsCanopy upgraded on economy reopening, Xeris PT cut on acquisition news, and more in analyst actionN/A
2021-07-21 23:44 ESTNewsStrongbridge issued patent for RECORLEV in treatment of Cushing’s SyndromeN/A
2021-07-21 23:18 ESTNewsThe Xeris-Strongbridge Merger Should Create Substantial Value For ShareholdersN/A
2021-07-21 23:04 ESTNewsStrongbridge highlights post hoc analyses from KEVEYIS PPP open label studyN/A
2021-04-22 22:03 ESTNewsStrongbridge: Approved Drugs, Near-Term Catalysts, Still Not ConvincedN/A
2021-04-07 21:08 ESTNewsStrongbridge spikes after peer-review publication of late-stage study on hormonal disorderN/A
2021-03-22 13:43 ESTNewsStrongbridge gains on detailed Phase 3 results for Recorlev in Cushing’s syndromeN/A
2021-03-20 02:01 ESTNewsMP, CLVS, SOS and TNXP among premarket gainersN/A
2021-03-05 00:45 ESTEarnings EstimateAn EPS average of -$0.23 is estimated for the 2022 year.Sell
2021-03-05 00:45 ESTEarnings EstimateAn EPS average of -$0.09 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-04 04:31 ESTFinancialsCompany financials have been released.Neutral
2021-03-03 13:27 ESTNewsStrongbridge Biopharma EPS in-line, beats on revenueN/A
2021-03-03 13:26 ESTNewsStrongbridge Biopharma plc 2020 Q4 - Results - Earnings Call PresentationN/A
2021-03-03 13:26 ESTNewsStrongbridge Biopharma plc's (SBBP) CEO John Johnson on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-16 15:35 ESTNewsStrongbridge names Richard Kollender as new President and CFON/A
2021-02-04 01:23 ESTNewsSizing Up Strongbridge Biopharma In 2021N/A
2021-01-06 10:27 ESTNewsStrongbridge Bio guides Q4 and FY20 revenue above consensus, shares up 3%N/A
2020-12-08 12:49 ESTAnalyst RatingThe Analyst Target Price has increased from $7.8 to $8.Buy
2020-11-26 21:27 ESTFinancialsCompany financials have been released.Neutral
2020-11-25 13:24 ESTAnalyst RatingThe Analyst Target Price has increased from $7.67 to $7.8.Buy
2020-11-22 02:24 ESTNewsStrongbridge Biopharma: $2.50 Biotech Stock Finally Seeing Some MomentumN/A
2020-11-12 05:11 ESTAnalyst RatingThe Analyst Target Price has increased from $7.5 to $7.67.Buy
2020-11-10 13:06 ESTAnalyst RatingThe Analyst Target Price has increased from $7.14 to $7.5.Buy
2020-11-08 00:49 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:03 ESTFinancialsCompany financials have been released.Neutral
2020-11-03 08:57 ESTNewsStrongbridge Biopharma plc 2020 Q3 - Results - Earnings Call PresentationN/A
2020-11-02 18:37 ESTAnalyst RatingThe Analyst Target Price has decreased from $8.29 to $7.14.Neutral
2020-11-02 00:41 ESTFinancialsCompany financials have been released.Neutral
2020-11-01 01:47 ESTNewsStrongbridge Biopharma EPS beats by $0.01, beats on revenueN/A
2020-11-01 01:44 ESTNewsStrongbridge Biopharma plc (SBBP) CEO John Johnson on Q3 2020 Results - Earnings Call TranscriptN/A
2020-10-30 21:56 ESTEarnings EstimateAn EPS average of -$0.06 is estimated for the quarter ending on March 31, 2021.Buy
2020-10-27 01:23 ESTNewsCrinetics Pharma lead drug successful in mid-stage acromegaly studyN/A
2020-09-28 07:57 ESTInsider TradeDAVID N GILL has directly acquired 8,000 shares and currently holds 74,896 shares.Buy
2020-09-26 13:58 ESTFinancialsCompany financials have been released.Neutral
2020-09-21 22:13 ESTInsider TradeCDK ASSOCIATES, L.L.C. has directly acquired 6,000 shares and currently holds 8,060,682 shares.Buy
2020-09-21 22:13 ESTInsider TradeCDK ASSOCIATES, L.L.C. has directly acquired 1,473,377 shares and currently holds 8,054,682 shares.Buy
2020-09-17 06:10 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:23 ESTNewsStrongbridge Biopharma readies equity offeringN/A
2020-09-17 05:23 ESTNewsStrongbridge Bio raises $25M by public offeringN/A
2020-09-13 15:44 ESTNewsStrongbridge Appears An Incredible Value After Releasing Recorlev's Phase 3 DataN/A
2020-09-09 13:28 ESTAnalyst RatingThe Analyst Target Price has increased from $8.14 to $8.29.Buy
2020-09-08 23:39 ESTNewsStrongbridge Biopharma's Recorlev successful in Cushing's syndrome studyN/A
2020-09-05 13:05 ESTNewsCrinetics Pharma to advance ACTH antagonist candidate into the clinicN/A
2020-08-14 10:03 ESTFinancialsCompany financials have been released.Neutral
2020-08-10 21:18 ESTNewsStrongbridge Biopharma's Recorlev Phase 3 Topline Data Due September 2020 Is A Major Value Inflection PointN/A

About Strongbridge Biopharma plc (SBBP):

Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs in the United States. The company offers Keveyis, an oral carbonic anhydrase inhibitor to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis. Its clinical-stage product candidates include Recorlev, a cortisol synthesis inhibitor, which is in Phase III clinical trials for the treatment of endogenous Cushing's syndrome; and Veldoreotide, a somatostatin analog that has completed Phase II clinical trial for the treatment of acromegaly. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is based in Trevose, Pennsylvania.

SBBP Quotes by TradingView

See Advanced Chart

General

  • Name Strongbridge Biopharma plc
  • Symbol SBBP
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 72
  • Fiscal Year EndDecember
  • IPO Date2015-10-16
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.strongbridgebio.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 5.62
  • Price/Book (Most Recent Quarter) 3.07
  • Enterprise Value Revenue 4.66
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.36
  • Next Year EPS Estimate -$0.12
  • Next Quarter EPS Estimate -$0.11
  • Profit Margin -147%
  • Operating Margin -139%
  • Return on Assets -22%
  • Return on Equity -65%
  • Revenue 30.73 million
  • Earnings Per Share $0.62
  • Revenue Per Share $0.53
  • Gross Profit 28.52 million
  • Quarterly Earnings Growth 46.7%
View More

Highlights

  • Market Capitalization 236.29 million
  • EBITDA -74521000
  • Analyst Target Price $8
  • Book Value Per Share $0.98
View More

Share Statistics

  • Shares Outstanding 67.51 million
  • Shares Float 39.88 million
  • % Held by Insiders 911%
  • % Held by Institutions 71.18%
  • Shares Short 593370
  • Shares Short Prior Month 694462
  • Short Ratio 0.56
  • Short % of Float 1%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 1.72
  • 52 Week High $4.44
  • 52 Week Low $1.65
  • 50 Day Moving Average 3.12
  • 200 Day Moving Average 2.69
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Strongbridge Biopharma plc (SBBP) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Strongbridge Biopharma plc (SBBP) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-03$8.23 million-$0.11-$0.112.91%
2020-09-302020-10-29$N/A-$0.12-$0.135.29%
2020-06-302020-08-04$7.76 million-$0.12-$0.2040%
2020-03-312020-05-06$N/A-$0.19-$0.2318.1%
2019-12-312020-02-25$5.61 million-$0.25-$0.275.66%
2019-09-302019-11-07$5.68 million-$0.25-$0.289.09%
2019-06-302019-07-31$6.08 million-$0.24-$0.2710.45%
2019-03-312019-05-01$4.34 million-$0.25-$0.3324.81%
2018-12-312019-02-26$4.51 million-$0.46-$0.519.45%
2018-09-302018-10-31$5.35 million-$0.47-$0.45-4.44%
2018-06-302018-08-08$4.3 million-$0.36-$0.4824.21%
2018-03-312018-05-10$3.87 million-$0.33-$0.3915.92%
2017-12-312018-03-12$2.98 million-$0.31-$0.323.73%
2017-09-302017-11-14$2.53 million-$0.35-$0.388.5%
2017-06-302017-08-07$1.53 million-$0.34-$0.34-0.74%
2017-03-312017-05-16$N/A-$0.41-$0.4915.9%
2016-12-312017-03-27$N/A-$0.29-$0.26-11.15%
2016-09-302016-12-23$N/A-$0.36-$0.397.69%
2016-06-302016-08-31$N/A-$0.61-$0.40-51.4%
2016-03-312016-05-17$N/A-$0.57-$0.55-4.26%

Strongbridge Biopharma plc (SBBP) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Strongbridge Biopharma plc (SBBP) Chart:

Strongbridge Biopharma plc (SBBP) News:

Below you will find a list of latest news for Strongbridge Biopharma plc (SBBP) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Strongbridge Biopharma plc (SBBP) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Strongbridge Biopharma plc (SBBP) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443220000027/0001634432-20-000027-index.htm
2018-07-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000091957418004815/0000919574-18-004815-index.htm
2018-07-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000091957418004871/0000919574-18-004871-index.htm
2018-07-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000091957418004961/0000919574-18-004961-index.htm
2018-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000091957418005044/0000919574-18-005044-index.htm
2018-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000091957418005198/0000919574-18-005198-index.htm
2018-08-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1634432/000091957418005872/0000919574-18-005872-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000091957418008127/0000919574-18-008127-index.htm
2018-12-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000091957418008212/0000919574-18-008212-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1634432/000091957419001191/0000919574-19-001191-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1634432/000091957419001686/0000919574-19-001686-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1634432/000091957420001128/0000919574-20-001128-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1634432/000091957420001416/0000919574-20-001416-index.htm
2020-09-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000091957420005947/0000919574-20-005947-index.htm
2020-09-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1634432/000091957420005961/0000919574-20-005961-index.htm
2018-12-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1634432/000095010318014866/0000950103-18-014866-index.htm
2018-08-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1634432/000104746918005606/0001047469-18-005606-index.htm
2020-09-16424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1634432/000104746920004899/0001047469-20-004899-index.htm
2020-09-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1634432/000104746920004917/0001047469-20-004917-index.htm
2018-03-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1634432/000110465918020314/0001104659-18-020314-index.htm
2018-03-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1634432/000110465918020315/0001104659-18-020315-index.htm
2018-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465918030066/0001104659-18-030066-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465918031959/0001104659-18-031959-index.htm
2018-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465918033971/0001104659-18-033971-index.htm
2018-05-31S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1634432/000110465918037145/0001104659-18-037145-index.htm
2018-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465918039312/0001104659-18-039312-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465918050315/0001104659-18-050315-index.htm
2018-08-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465918052343/0001104659-18-052343-index.htm
2018-08-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465918053799/0001104659-18-053799-index.htm
2018-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465918063164/0001104659-18-063164-index.htm
2018-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465918064932/0001104659-18-064932-index.htm
2018-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465918065143/0001104659-18-065143-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465918073693/0001104659-18-073693-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465919010492/0001104659-19-010492-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465919013519/0001104659-19-013519-index.htm
2019-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465919013732/0001104659-19-013732-index.htm
2019-04-18S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1634432/000110465919022114/0001104659-19-022114-index.htm
2019-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465919025705/0001104659-19-025705-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465919059792/0001104659-19-059792-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465920024477/0001104659-20-024477-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000110465920024516/0001104659-20-024516-index.htm
2020-03-17PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1634432/000110465920034828/0001104659-20-034828-index.htm
2020-04-01DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1634432/000110465920041860/0001104659-20-041860-index.htm
2019-02-01SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1634432/000114036119002245/0001140361-19-002245-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1634432/000114036120002487/0001140361-20-002487-index.htm
2018-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911018006948/0001179110-18-006948-index.htm
2018-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911018006949/0001179110-18-006949-index.htm
2018-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911018006950/0001179110-18-006950-index.htm
2018-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911018006951/0001179110-18-006951-index.htm
2018-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911018006952/0001179110-18-006952-index.htm
2018-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911018006954/0001179110-18-006954-index.htm
2018-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911018009896/0001179110-18-009896-index.htm
2018-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911018013212/0001179110-18-013212-index.htm
2019-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019002283/0001179110-19-002283-index.htm
2019-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019002284/0001179110-19-002284-index.htm
2019-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019002285/0001179110-19-002285-index.htm
2019-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019002286/0001179110-19-002286-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019006149/0001179110-19-006149-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019006151/0001179110-19-006151-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019006152/0001179110-19-006152-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019006153/0001179110-19-006153-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019006155/0001179110-19-006155-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019006156/0001179110-19-006156-index.htm
2019-06-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019007207/0001179110-19-007207-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019007208/0001179110-19-007208-index.htm
2019-09-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019010057/0001179110-19-010057-index.htm
2019-09-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019010058/0001179110-19-010058-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019010059/0001179110-19-010059-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019010061/0001179110-19-010061-index.htm
2019-11-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911019011796/0001179110-19-011796-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020000874/0001179110-20-000874-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020000875/0001179110-20-000875-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020000876/0001179110-20-000876-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020000877/0001179110-20-000877-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020000878/0001179110-20-000878-index.htm
2020-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020004824/0001179110-20-004824-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020006098/0001179110-20-006098-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020006099/0001179110-20-006099-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020006105/0001179110-20-006105-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020006109/0001179110-20-006109-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020006113/0001179110-20-006113-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020006239/0001179110-20-006239-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020006240/0001179110-20-006240-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020006241/0001179110-20-006241-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020006242/0001179110-20-006242-index.htm
2020-05-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020006243/0001179110-20-006243-index.htm
2020-07-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020008088/0001179110-20-008088-index.htm
2020-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020009587/0001179110-20-009587-index.htm
2020-09-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1634432/000117911020009968/0001179110-20-009968-index.htm
2018-11-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1634432/000119312518323091/0001193125-18-323091-index.htm
2018-12-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1634432/000119312518361016/0001193125-18-361016-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1634432/000119312519036151/0001193125-19-036151-index.htm
2020-03-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1634432/000119312520079202/0001193125-20-079202-index.htm
2018-06-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1634432/000149315218009119/0001493152-18-009119-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1634432/000149315219002113/0001493152-19-002113-index.htm
2018-04-13DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1634432/000155837018002951/0001558370-18-002951-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1634432/000155837018004576/0001558370-18-004576-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1634432/000155837018006678/0001558370-18-006678-index.htm
2018-10-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1634432/000155837018008155/0001558370-18-008155-index.htm
2019-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1634432/000155837019001146/0001558370-19-001146-index.htm
2019-04-12DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1634432/000155837019002947/0001558370-19-002947-index.htm
2019-05-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1634432/000155837019003684/0001558370-19-003684-index.htm
2019-05-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000155837019005141/0001558370-19-005141-index.htm
2019-07-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1634432/000155837019006619/0001558370-19-006619-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1634432/000155837019010288/0001558370-19-010288-index.htm
2019-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000155837019011116/0001558370-19-011116-index.htm
2020-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1634432/000155837020001720/0001558370-20-001720-index.htm
2020-04-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1634432/000155837020004047/0001558370-20-004047-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1634432/000155837020005292/0001558370-20-005292-index.htm
2020-08-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1634432/000155837020009071/0001558370-20-009071-index.htm
2020-09-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000155837020011032/0001558370-20-011032-index.htm
2020-10-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1634432/000155837020012063/0001558370-20-012063-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1634432/000161577419002514/0001615774-19-002514-index.htm
2019-07-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443219000004/0001634432-19-000004-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443219000007/0001634432-19-000007-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443219000010/0001634432-19-000010-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443219000013/0001634432-19-000013-index.htm
2019-11-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443219000015/0001634432-19-000015-index.htm
2019-11-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443219000017/0001634432-19-000017-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443220000004/0001634432-20-000004-index.htm
2020-01-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443220000007/0001634432-20-000007-index.htm
2020-03-05S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1634432/000163443220000011/0001634432-20-000011-index.htm
2020-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443220000015/0001634432-20-000015-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443220000018/0001634432-20-000018-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443220000021/0001634432-20-000021-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443220000025/0001634432-20-000025-index.htm
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443220000027/0001634432-20-000027-index.htm
2020-07-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443220000030/0001634432-20-000030-index.htm
2020-08-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443220000032/0001634432-20-000032-index.htm
2020-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443220000036/0001634432-20-000036-index.htm
2020-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1634432/000163443220000039/0001634432-20-000039-index.htm
2018-03-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1634432/999999999518000688/9999999995-18-000688-index.htm
2018-03-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1634432/999999999518000689/9999999995-18-000689-index.htm
2018-08-29CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1634432/999999999718007507/9999999997-18-007507-index.htm

Strongbridge Biopharma plc (SBBP) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Strongbridge Biopharma plc (SBBP). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 911%
Institutional Ownership: 7118%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-03Richard S KollenderChief Operating OfficerBuy60,000.00100,000.00https://www.sec.gov/Archives/edgar/data/1634432/000117911019010061/0001179110-19-010061-index.htm
2020-04-08JOHN JOHNSONExecutive ChairmanBuy182,500.00222,500.00https://www.sec.gov/Archives/edgar/data/1634432/000117911020004824/0001179110-20-004824-index.htm
2019-02-20STEPHEN J LONGChief Legal OfficerBuy20,000.0030,662.00https://www.sec.gov/Archives/edgar/data/1634432/000117911019002284/0001179110-19-002284-index.htm
2019-02-20A BRIAN DAVISChief Financial OfficerBuy20,000.0033,366.00https://www.sec.gov/Archives/edgar/data/1634432/000117911019002285/0001179110-19-002285-index.htm
2019-02-20Fredric J. CohenChief Medical OfficerBuy24,500.0037,934.00https://www.sec.gov/Archives/edgar/data/1634432/000117911019002286/0001179110-19-002286-index.htm
2019-05-15Garheng KongDirectorBuy40,000.0040,000.00https://www.sec.gov/Archives/edgar/data/1634432/000117911019006152/0001179110-19-006152-index.htm
2019-05-15Hilde H SteinegerDirectorBuy40,000.0040,000.00https://www.sec.gov/Archives/edgar/data/1634432/000117911019006156/0001179110-19-006156-index.htm
2019-05-15JEFFREY W SHERMANDirectorBuy40,000.0040,000.00https://www.sec.gov/Archives/edgar/data/1634432/000117911019006153/0001179110-19-006153-index.htm
2019-05-15JOHN JOHNSONDirectorBuy40,000.0040,000.00https://www.sec.gov/Archives/edgar/data/1634432/000117911019006149/0001179110-19-006149-index.htm
2019-05-15Marten SteenDirectorBuy40,000.0040,000.00https://www.sec.gov/Archives/edgar/data/1634432/000117911019006155/0001179110-19-006155-index.htm
2019-05-15Richard S KollenderDirectorBuy40,000.0040,000.00https://www.sec.gov/Archives/edgar/data/1634432/000117911019006151/0001179110-19-006151-index.htm
2019-09-03DAVID N GILLDirectorBuy50,000.0050,000.00https://www.sec.gov/Archives/edgar/data/1634432/000117911019010059/0001179110-19-010059-index.htm
2020-07-02JOHN JOHNSONChief Executive OfficerBuy315,000.00522,152.00https://www.sec.gov/Archives/edgar/data/1634432/000117911020008088/0001179110-20-008088-index.htm
2018-07-16CDK ASSOCIATES, L.L.C.10% Share HolderBuy11,200.004.9755,629.285,409,234.00https://www.sec.gov/Archives/edgar/data/1634432/000091957418004815/0000919574-18-004815-index.htm
2018-07-19CDK ASSOCIATES, L.L.C.10% Share HolderBuy14,000.004.9869,746.605,423,234.00https://www.sec.gov/Archives/edgar/data/1634432/000091957418004871/0000919574-18-004871-index.htm
2018-07-20CDK ASSOCIATES, L.L.C.10% Share HolderBuy21,100.004.97104,795.265,444,334.00https://www.sec.gov/Archives/edgar/data/1634432/000091957418004871/0000919574-18-004871-index.htm
2018-07-23CDK ASSOCIATES, L.L.C.10% Share HolderBuy20,400.004.95100,980.005,464,734.00https://www.sec.gov/Archives/edgar/data/1634432/000091957418004871/0000919574-18-004871-index.htm
2018-07-24CDK ASSOCIATES, L.L.C.10% Share HolderBuy150,000.004.92737,265.005,614,734.00https://www.sec.gov/Archives/edgar/data/1634432/000091957418004961/0000919574-18-004961-index.htm
2018-07-26CDK ASSOCIATES, L.L.C.10% Share HolderBuy39,800.004.94196,727.425,654,534.00https://www.sec.gov/Archives/edgar/data/1634432/000091957418004961/0000919574-18-004961-index.htm
2018-07-27CDK ASSOCIATES, L.L.C.10% Share HolderBuy116,900.004.63541,048.275,771,434.00https://www.sec.gov/Archives/edgar/data/1634432/000091957418004961/0000919574-18-004961-index.htm
2018-07-27CDK ASSOCIATES, L.L.C.10% Share HolderBuy92,400.004.85448,140.005,863,384.00https://www.sec.gov/Archives/edgar/data/1634432/000091957418004961/0000919574-18-004961-index.htm
2018-07-30CDK ASSOCIATES, L.L.C.10% Share HolderBuy70,000.004.66326,466.005,933,834.00https://www.sec.gov/Archives/edgar/data/1634432/000091957418005044/0000919574-18-005044-index.htm
2018-08-08CDK ASSOCIATES, L.L.C.10% Share HolderBuy360,995.004.931,778,514.076,294,829.00https://www.sec.gov/Archives/edgar/data/1634432/000091957418005198/0000919574-18-005198-index.htm
2018-12-20CDK ASSOCIATES, L.L.C.10% Share HolderBuy146,467.004.00585,384.666,441,296.00https://www.sec.gov/Archives/edgar/data/1634432/000091957418008127/0000919574-18-008127-index.htm
2018-12-21CDK ASSOCIATES, L.L.C.10% Share HolderBuy90,612.003.95357,989.896,531,908.00https://www.sec.gov/Archives/edgar/data/1634432/000091957418008127/0000919574-18-008127-index.htm
2018-12-26CDK ASSOCIATES, L.L.C.10% Share HolderBuy31,197.004.00124,697.536,563,105.00https://www.sec.gov/Archives/edgar/data/1634432/000091957418008212/0000919574-18-008212-index.htm
2018-12-27CDK ASSOCIATES, L.L.C.10% Share HolderBuy18,200.003.9872,434.186,581,305.00https://www.sec.gov/Archives/edgar/data/1634432/000091957418008212/0000919574-18-008212-index.htm
2019-02-20Matthew PaulsPresident & CEOBuy50,000.0072,608.00https://www.sec.gov/Archives/edgar/data/1634432/000117911019002283/0001179110-19-002283-index.htm
2020-09-24DAVID N GILLDirectorBuy8,000.002.1317,040.0074,896.00https://www.sec.gov/Archives/edgar/data/1634432/000117911020009968/0001179110-20-009968-index.htm
2020-05-14Garheng KongDirectorBuy40,000.0080,000.00https://www.sec.gov/Archives/edgar/data/1634432/000117911020006113/0001179110-20-006113-index.htm
2020-05-14Hilde H SteinegerDirectorBuy40,000.0080,000.00https://www.sec.gov/Archives/edgar/data/1634432/000117911020006105/0001179110-20-006105-index.htm
2020-05-14JEFFREY W SHERMANDirectorBuy40,000.0080,000.00https://www.sec.gov/Archives/edgar/data/1634432/000117911020006109/0001179110-20-006109-index.htm
2020-05-14Marten SteenDirectorBuy40,000.0080,000.00https://www.sec.gov/Archives/edgar/data/1634432/000117911020006098/0001179110-20-006098-index.htm
2020-09-17CDK ASSOCIATES, L.L.C.10% Share HolderBuy1,473,377.002.253,315,098.258,054,682.00https://www.sec.gov/Archives/edgar/data/1634432/000091957420005947/0000919574-20-005947-index.htm
2020-09-18CDK ASSOCIATES, L.L.C.10% Share HolderBuy6,000.002.2013,200.008,060,682.00https://www.sec.gov/Archives/edgar/data/1634432/000091957420005947/0000919574-20-005947-index.htm
2020-05-14DAVID N GILLDirectorBuy40,000.0090,000.00https://www.sec.gov/Archives/edgar/data/1634432/000117911020006099/0001179110-20-006099-index.htm